Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
MITRAL STENOSIS WITH
PREGNANCY
- DR. ANKITA PATNI
- ANAESTHESIOLOGY
INTRODUCTION
• Rheumatic mitral stenosis forms 88% of the heart
diseases complicating pregnancy in the tertiary
referral c...
CARDIOVASCULAR CHANGES DURING
PREGNANCY
Parameter Percentage of change
Cardiac output 40–50% Increase
Stroke volume 30% In...
HEMODYNAMICS DURING LABOUR
Parameter Stage of labour Percentage of change
Cardiac output Latent phase 10% Increase
Active ...
HEMODYNAMICS DURING PUERPERIUM
Parameter Post-partum Percentage of Change
Cardiac output Within 1 h 30% above pre-labour v...
MS PREGNANCY
DELIVERY
DECREAS
E LA
emptying
DECREAS
E LV
Filling
INCREASE
HR
DECREASE
SV
DECREASE
CO
Fixed CO state; Heart...
• MS- impairs left ventricular
filling- decrease in EDV (pre-
load)- decrease in SV- fall in
CO.
• Reduced ventricular fil...
SEVERITY GRADING OF MS
Measuremen
t
Normal Mild Moderate Severe
Mitral valve area
(cm2)
4.0–6.0 1.5–2.5 1.0–1.5 <1.0
Mean ...
4-6 cms2
< 2.5 cms2
1.5- 2.5 cms2
1.0 – 1.5 cms2
< 1.0 cms2
Mild MS – 1.5 – 2.5
Cms2 (Dyspnea on
severe exertion)
Moderate...
MODIFIED NEW YORK HEART ASSOCIATION
FUNCTIONAL CLASSIFICATION (NYHA)
Class I No functional
limitation of activity
Asymptom...
PREDICTORS OF MORTALITY AND MORBIDITY
Severity of MS
Severe- 67%
Moderate- 38%
Mild- 26%
NYHA Class
Class I and II- <1%
Cl...
CARPREG SCORE
• THE CARDIAC DISEASE IN PREGNANCY (CARPREG) RISK SCORE (TABLE I) CAN BE
CALCULATED TO ESTIMATE A WOMAN'S CA...
AETIOLOGY OF MS
1. RHEUMATIC HEART DISEASE
2. CONGENITAL – PARACHUTE MITRAL
VALVE
3. HUNTER’S SYNDROME
4. HURLER’S SYNDROM...
SYMPTOMS OF MS
1. DYSPNOEA
2. ORTHOPNEA
3. PAROXYSMAL NOCTURNAL
DYSPNEA
4. PALPITATION
5. FATIGUABILITY
6. HAEMOPTYSIS
7. ...
DIAGNOSIS OF MS
DIAGNOSTIC
TOOLS
Clinical
Examina
tion
ECG
Chest X-
Ray
Echocardi
ography
Doppler
examinati
on
Cardiac
Cat...
GENERAL PHYSICAL EXAMINATION
OEDEMA
SEVERE MITRAL
STENOSIS
ULTIMATELY
LEADS TO RIGHT
HEART FAILURE.
HEPATOMEGALY
SEEN IN R...
CARDIOVASCULAR EXAMINATION-
INSPECTION
• PRECORDIAL BULGE INDICATES EARLY ONSET AND LONGER
DURATION OF CARDIAC DISEASE.
• ...
CARDIOVASCULAR EXAMINATION-
PALPATION
• TAPPING CHARACTER OF THE APEX BEAT (PALPABLE S1) IS TYPICAL.
• PALPABLE DIASTOLIC ...
CARDIOVASCULAR EXAMINATION-
AUSCULTATION
• S1 IS SHARP, SHORT, ACCENTUATED
• OPENING SNAP AFTER S2
• LOW PITCHED MID-DIAST...
ECG FINDINGS
1. BROAD NOTCHED “P” WAVES SIGNIFYING ATRIAL ENLARGEMENT.
2. ATRIAL FIBRILLATION (F- WAVES REPLACING P-WAVES)...
CXR
1. LEFT ATRIAL ENLARGEMENT –
MITRALISATION OF HEART
2. STRAIGHTENING OF LEFT HEART
BORDER
3. ELEVATION OF LEFT MAINSTE...
CHEST X-RAY
Kerley
b lines
ECHOCARDIOGRAPHY
MANAGEMENT
MEDICAL
DIURETICS, β-
BLOCKERS
AF- DIGOXIN,
ANTI-COAGULANTS
SURGICAL
VALVULOPLASTY
VALVE
REPLACEMENT
OBSTETRICA...
MEDICAL MANAGEMENT
FIRST LINE OF TREATMENT IN
SYMPTOMATICS
• BED REST
• OXYGEN THERAPY
• DIURETICS
• BETA-ADRENERGIC RECEP...
ANTICOAGULATION DURING PREGNANCY
• SC/IV HEPARIN FOR UP TO 12 WEEKS ANTEPARTUM (APTT 1.5–2.5-TIMES OF
NORMAL)
• WARFARIN F...
SURGICAL MANAGEMENT
II Trimester
Valvuloplasty
PERCUTANEOUS (success rate is
nearly 100%. It increases the valve area to
>...
OBSTETRIC MANAGEMENT
VAGINAL
DELIVERY
• Tachycardia, secondary to
labour pain, increases
flow across the mitral
valve, pro...
OBSTETRIC MANAGEMENT
Caesarean
section
Epidural/Spinal
Combined Spinal
Epidural
General
Anaesthesia
Only for obstetric
rea...
OBSTETRIC MANAGEMENT
Category 1 - Immediate
threat to life of woman or
fetus (baby needs to be
removed in 30 min. of
makin...
GOALS FOR ANAESTHETIC MANAGEMENT
• MAINTENANCE OF AN ACCEPTABLE SLOW HEART RATE
• IMMEDIATE TREATMENT OF ACUTE ATRIAL FIBR...
EPIDURAL ANALGESIA
• ONE OF THE MAJOR ADVANTAGES OF EPIDURAL ANALGESIA IS THAT IT CAN BE
ADMINISTERED IN INCREMENTAL DOSES...
COMBINED SPINAL-EPIDURAL
PROCEDURE PER SE
• CSE IS PERFORMED IN LATERAL DECUBITUS POSITION UNDER STRICT ASEPTIC PRECAUTION...
MYTHS AND WORRIES ABOUT REGIONAL
ANAESTHESIA
1. PRELOADING IS MANDATORY AND HAZARDOUS--CVP GUIDED FLUID
MANAGEMENT NEGATES...
REGIONAL ANAESTHESIA
CONTROVERSIES ABOUT CSE:
• RISK OF EPIDURAL CATHETER
THROUGH THE DURAL HOLE
• PERCEIVED INCREASE IN
N...
GUIDELINES FOR
GENERAL
ANAESTHESIA
• ANAESTHETIC GOALS:
1. MAINTAIN THE HEART RATE AROUND 80-100
B/MIN .
2. MAINTAIN LEFT ...
ANAESTHETIC GOALS
5. AVOID FACTORS WHICH DEPRESS THE MYOCARDIUM (INHALATION AGENTS AND DRUGS)
6. MAINTAIN AWARENESS OF POT...
GENERAL ANAESTHESIA
• INDUCTION OF ANAESTHESIA
1. AVOID KETAMINE× – INCREASES HEART RATE, BLOOD PRESSURE
2. AVOID ATRACURI...
GENERAL ANAESTHESIA
• MAINTENANCE OF ANAESTHESIA
1. DRUGS SHOULD HAVE MINIMAL EFFECTS ON HEMODYNAMIC PATTERN
2. BALANCED A...
GENERAL ANAESTHESIA
• AFTER DELIVERY OF THE FOETUS, OXYTOCIN 10–20 U IN 1,000 ML OF CRYSTALLOID
SHOULD BE ADMINISTERED AT ...
ADVANTAGES OF GA
1. RAPIDLY ESTABLISHED
2. BETTER HEMODYNAMIC STABILITY
3. PREVENTION OF ASPIRATION AS THE
AIRWAY IS ISOLA...
COMPLICATIONS OF GA
1. FAILED INTUBATION
2. ASPIRATION( MORE COMMON IN
UNPREPARED CASE)
3. HYPERTENSIVE CRISIS
4. ARRHYTHM...
OUTLINES OF MANAGEMENT
1. PRE-CONCEPTUAL COUNSELING- NYHA III AND IV ARE ADVISED CORRECTIVE
CARDIAC BEFORE PREGNANCY. IT I...
OUTLINES OF MANAGEMENT
4. OPTIMIZATION OF HEART RATE WITH PHARMACOLOGICAL AGENTS
5. PREGNANCY IS A HYPERCOAGULABLE STATE, ...
OUTLINES OF MANAGEMENT
8. PLANNING THE MODE OF DELIVERY-VAGINAL DELIVERY IS BETTER TOLERATED(LESS BLOOD
LOSS, LESS CATECHO...
THANK YOU
Mitral stenosis with pregnancy
Nächste SlideShare
Wird geladen in …5
×
Nächste SlideShare
Heart disease in pregnancy
Weiter
Herunterladen, um offline zu lesen und im Vollbildmodus anzuzeigen.

102

Teilen

Herunterladen, um offline zu lesen

Mitral stenosis with pregnancy

Herunterladen, um offline zu lesen

Anaesthesiology

Ähnliche Bücher

Kostenlos mit einer 30-tägigen Testversion von Scribd

Alle anzeigen

Mitral stenosis with pregnancy

  1. 1. MITRAL STENOSIS WITH PREGNANCY - DR. ANKITA PATNI - ANAESTHESIOLOGY
  2. 2. INTRODUCTION • Rheumatic mitral stenosis forms 88% of the heart diseases complicating pregnancy in the tertiary referral centre in India. • Rheumatic mitral stenosis complicating pregnancy is still a frequent cause of maternal death. • A better understanding of the physiological changes in pregnancy and the pathological impact of mitral stenosis over pregnancy and a multidisciplinary approach; where the anaesthesiologist plays a major role, in diagnosis and management, reduce the mortality and morbidity.
  3. 3. CARDIOVASCULAR CHANGES DURING PREGNANCY Parameter Percentage of change Cardiac output 40–50% Increase Stroke volume 30% Increase Heart rate 15–25% Increase Intravascular volume 45% Increase Systemic vascular resistance 20% Decrease Systolic BP Minimal Diastolic BP 20% Decrease at mid-pregnancy Pre-pregnant values at term CVP Unchanged O2 consumption 30–40% Increase
  4. 4. HEMODYNAMICS DURING LABOUR Parameter Stage of labour Percentage of change Cardiac output Latent phase 10% Increase Active phase 25% Increase Expulsive phase 40% Increase Immediate post-partum 75–80% Increase Heart rate All stages Increase CVP All stages Increase
  5. 5. HEMODYNAMICS DURING PUERPERIUM Parameter Post-partum Percentage of Change Cardiac output Within 1 h 30% above pre-labour values 24–48 h Just below pre-labour values 2 weeks 10% above pre-pregnant values 12–24 weeks Baseline pre-pregnancy values Heart rate Immediate Decrease 2 weeks Pre-pregnant values Stroke volume 48 h Remains above pre-labour values 24 weeks 10% above pre-pregnant values
  6. 6. MS PREGNANCY DELIVERY DECREAS E LA emptying DECREAS E LV Filling INCREASE HR DECREASE SV DECREASE CO Fixed CO state; Heart cannot cope up with increased demand. AUTOTRANSFUSION from uterus PULMONARY CONGESTION Long- standin g Irreversible chronic Pulmonary Hypertension LA Dilates LA pressure INCREASES At DIASTOL E Pressure gradient develop s between LA and LVHemodynam ic Hallmark of MS
  7. 7. • MS- impairs left ventricular filling- decrease in EDV (pre- load)- decrease in SV- fall in CO. • Reduced ventricular filling- decrease ventricular wall stress (after-load)- decrease in ESV • Decrease in EDV > Decrease in ESV = Decrease in SV
  8. 8. SEVERITY GRADING OF MS Measuremen t Normal Mild Moderate Severe Mitral valve area (cm2) 4.0–6.0 1.5–2.5 1.0–1.5 <1.0 Mean pressure gradient (mmHg) <2 2–6 6–12 >12 Pulmonary artery mean pressure (mmHg) 10–20 <30 30–50 >50
  9. 9. 4-6 cms2 < 2.5 cms2 1.5- 2.5 cms2 1.0 – 1.5 cms2 < 1.0 cms2 Mild MS – 1.5 – 2.5 Cms2 (Dyspnea on severe exertion) Moderate MS – 1.0 – 1.5 Cms2 (PND ± pulmonary oedema) Severe/ Critical- < 1.0 Cms2 (Orthopnea – Class IV) Symptoms start < 2.5 Cms2 Normal Orifice: 4 – 6 Cms2
  10. 10. MODIFIED NEW YORK HEART ASSOCIATION FUNCTIONAL CLASSIFICATION (NYHA) Class I No functional limitation of activity Asymptomatic except during severe exertion. Class II Mild limitation of physical activity Symptomatic with moderate activity Class III Marked limitation of physical activity Symptomatic with minimal activity Class IV Severe limitation of physical activity Symptomatic at rest
  11. 11. PREDICTORS OF MORTALITY AND MORBIDITY Severity of MS Severe- 67% Moderate- 38% Mild- 26% NYHA Class Class I and II- <1% Class III and IV- Between 5 and 15% Class III and IV- Perinatal mortality- 20- 30%
  12. 12. CARPREG SCORE • THE CARDIAC DISEASE IN PREGNANCY (CARPREG) RISK SCORE (TABLE I) CAN BE CALCULATED TO ESTIMATE A WOMAN'S CARDIAC RISK DURING PREGNANCY. IT IS IS BASED ON 4 RISK PREDICTORS: Mortality: 0 point-5%, 1 point-27%, >1 point- 75%
  13. 13. AETIOLOGY OF MS 1. RHEUMATIC HEART DISEASE 2. CONGENITAL – PARACHUTE MITRAL VALVE 3. HUNTER’S SYNDROME 4. HURLER’S SYNDROME 5. DRUGS – METHYSERGIDE 6. CARCINOID SYNDROME 7. AMYLOIDOSIS 8. MITRAL ANNULAR CALCIFICATION 9. RHEUMATOID ARTHRITIS 10. SYSTEMIC LUPUS ERYTHEMATOSIS 11. INFECTIVE ENDOCARDITIS WITH LARGE VEGETATIONS. 12. LUTEMBACHER’S SYNDROME: ATRIAL SEPTAL DEFECT (ASD) + MITRAL STENOSIS (MS) RHEUMATIC ORIGIN
  14. 14. SYMPTOMS OF MS 1. DYSPNOEA 2. ORTHOPNEA 3. PAROXYSMAL NOCTURNAL DYSPNEA 4. PALPITATION 5. FATIGUABILITY 6. HAEMOPTYSIS 7. RECURRENT BRONCHITIS 8. COUGH 9. CHEST PAIN 10. RIGHT HYPOCHONDRIAL PAIN (HEPATOMEGALY)
  15. 15. DIAGNOSIS OF MS DIAGNOSTIC TOOLS Clinical Examina tion ECG Chest X- Ray Echocardi ography Doppler examinati on Cardiac Catheteriz ation Echocardiography provides information regarding the area of the mitral valve, size of the left atrium, presence of thrombus and the size and function of the left ventricle and Doppler examination provides information about the severity of the stenosis, the presence of other associated valve lesions and the degree of pulmonary hypertension Diagnostic cardiac catheterization is necessary only when echocardiography is non-diagnostic or results are discordant with clinical findings.
  16. 16. GENERAL PHYSICAL EXAMINATION OEDEMA SEVERE MITRAL STENOSIS ULTIMATELY LEADS TO RIGHT HEART FAILURE. HEPATOMEGALY SEEN IN RIGHT VENTRICULAR FAILURE AND PULMONARY HYPERTENSION. MITRAL FACIES LOW CARDIAC OUTPUT IN MITRAL STENOSIS CAUSES PERIPHERAL VASOCONSTRICTION PRODUCING PINKISH PURPLE PATCHES ON CHEEKS. MITRAL FLUSH DUE TO VASODILATATION (VASCULAR STASIS) IS SEEN SEEN IN FAIR SKINNED INDIVIDUALS
  17. 17. CARDIOVASCULAR EXAMINATION- INSPECTION • PRECORDIAL BULGE INDICATES EARLY ONSET AND LONGER DURATION OF CARDIAC DISEASE. • SCAR MARKS REVEAL PREVIOUS SURGERIES • ENGORGED NECK VEINS INDICATE HIGH RIGHT HEART PRESSURES
  18. 18. CARDIOVASCULAR EXAMINATION- PALPATION • TAPPING CHARACTER OF THE APEX BEAT (PALPABLE S1) IS TYPICAL. • PALPABLE DIASTOLIC THRILL IN MITRAL AREA BEST FELT IN LEFT LATERAL POSITION IN FULL EXPIRATION. • PARASTERNAL HEAVE • IF ONE FINDS ENGORGED SUPERFICIAL VEINS LOOK FOR DIRECTION OF FLOW.
  19. 19. CARDIOVASCULAR EXAMINATION- AUSCULTATION • S1 IS SHARP, SHORT, ACCENTUATED • OPENING SNAP AFTER S2 • LOW PITCHED MID-DIASTOLIC RUMBLING MURMUR WITH PRESYSTOLIC ACCENTUATION IN MITRAL AREA. • MURMUR BEST HEARD AT CARDIAC APEX WITH BELL OF STETHOSCOPE IN LEFT LATERAL POSITION AT HEIGHT OF EXPIRATION
  20. 20. ECG FINDINGS 1. BROAD NOTCHED “P” WAVES SIGNIFYING ATRIAL ENLARGEMENT. 2. ATRIAL FIBRILLATION (F- WAVES REPLACING P-WAVES) 3. RIGHT VENTRICULAR ENLARGEMENT
  21. 21. CXR 1. LEFT ATRIAL ENLARGEMENT – MITRALISATION OF HEART 2. STRAIGHTENING OF LEFT HEART BORDER 3. ELEVATION OF LEFT MAINSTEM BRONCHUS 4. EVIDENCE OF MITRAL CALCIFICATION, EVIDENCE OF PULMONARY EDEMA, PULMONARY VASCULAR CONGESTION. 5. KERLEY’S B LINES 6. DOUBLE CONTOUR OF THE RIGHT BORDER OF HEART
  22. 22. CHEST X-RAY Kerley b lines
  23. 23. ECHOCARDIOGRAPHY
  24. 24. MANAGEMENT MEDICAL DIURETICS, β- BLOCKERS AF- DIGOXIN, ANTI-COAGULANTS SURGICAL VALVULOPLASTY VALVE REPLACEMENT OBSTETRICAL VAGINAL CAESAREAN SECTION
  25. 25. MEDICAL MANAGEMENT FIRST LINE OF TREATMENT IN SYMPTOMATICS • BED REST • OXYGEN THERAPY • DIURETICS • BETA-ADRENERGIC RECEPTOR BLOCKADE- USEFUL TO PREVENT TACHYCARDIA DURING PREGNANCY. PROPRANOLOL OR ATENOLOL DECREASES THE INCIDENCE OF MATERNAL PULMONARY OEDEMA WITHOUT ADVERSE EFFECTS ON THE FOETUS OR NEONATE. • ANTIBIOTIC PROPHYLAXIS FOR ENDOCARDITIS IS RESERVED ONLY FOR PATIENTS WITH A PREVIOUS HISTORY OF ENDOCARDITIS OR PRESENCE OF ESTABLISHED INFECTION. ASSOCIATED WITH ATRIAL FIBRILLATION • DIGOXIN AND BETA BLOCKERS TO REVERT IT TO SINUS RHYTHM. • ANTICOAGULATION TO PREVENT SYSTEMIC EMBOLIZATION. • CARDIOVERSION SHOULD BE PERFORMED IF PHARMACOLOGIC THERAPY FAILS TO CONTROL THE VENTRICULAR RESPONSE.
  26. 26. ANTICOAGULATION DURING PREGNANCY • SC/IV HEPARIN FOR UP TO 12 WEEKS ANTEPARTUM (APTT 1.5–2.5-TIMES OF NORMAL) • WARFARIN FROM 12 TO 36 WEEKS (MAINTAIN INR 2.5– 3.0) • SC/IV HEPARIN AFTER 36 WEEKS • THERAPY WITH LOW-MOLECULAR WEIGHT HEPARIN (LMWH) INSTEAD OF UNFRACTIONATED HEPARIN IS GAINING POPULARITY. ALTHOUGH AN “ANTI XA” ACTIVITY IS USED TO MONITOR LMWH, NO ANTI-XA ACTIVITY-BASED GUIDELINES HAVE BEEN ISSUED TILL DATE.
  27. 27. SURGICAL MANAGEMENT II Trimester Valvuloplasty PERCUTANEOUS (success rate is nearly 100%. It increases the valve area to >1.5 cm2 without a substantial increase in mitral regurgitation.) OPEN (foetal loss is high in open commissurotomy as compared to percutaneous, at a ratio of 1:8) Valve Replacement Reserved for severe cases with calcified valve and in mural thrombus.
  28. 28. OBSTETRIC MANAGEMENT VAGINAL DELIVERY • Tachycardia, secondary to labour pain, increases flow across the mitral valve, producing sudden rises in left atrial pressure, leading to acute pulmonary oedema. VAGINAL DELIVERY • The second stage of delivery should be cut short by instrumentation. • Maintenance of left uterine displacement for good venous return. • Supplemental oxygen administration with pulse oximetry monitoring to minimize increases in pulmonary vascular resistance, fetal heart rate monitoring should be carried out. • Invasive cardiac monitoring like radial artery cannulation and pulmonary catheter are beneficial in assessing the cardiac output, pulmonary artery pressure and for guiding fluid and drug therapy, especially in NYHA III and IV patients. • Sudden drops in systemic vascular resistance (SVR) in the presence of a fixed cardiac output can be prevented by small bolus doses of phenylephrine, with volume expansion when necessary. Good LABOUR ANALGESIA is must. Epidural CS E
  29. 29. OBSTETRIC MANAGEMENT Caesarean section Epidural/Spinal Combined Spinal Epidural General Anaesthesia Only for obstetric reasons Epidural anaesthesia might not be an ideal technique as it requires slow induction, delay in the onset of action which may not be possible in an emergency situation. Moreover large volume of local anesthetic is needed for adequate blockade. Subarachnoid causes rapid onset of extensive sympathetic blockade with intense vasodilatation, sudden hypotension and severe tachycardia. Technique of choice. CSE offers rapid onset and improved analgesia It offers ability to use low dose spinal with room for post operative analgesia
  30. 30. OBSTETRIC MANAGEMENT Category 1 - Immediate threat to life of woman or fetus (baby needs to be removed in 30 min. of making the decision to do LSCS) Category 2 - Maternal or fetal compromise, not immediately life threatening(some time can be spent for resuscitation) Category 4- At a time to suit the woman and maternity team Category 3 - Needing early delivery but no maternal or fetal compromise
  31. 31. GOALS FOR ANAESTHETIC MANAGEMENT • MAINTENANCE OF AN ACCEPTABLE SLOW HEART RATE • IMMEDIATE TREATMENT OF ACUTE ATRIAL FIBRILLATION AND REVERSION TO SINUS RHYTHM • AVOIDANCE OF AORTOCAVAL COMPRESSION • MAINTENANCE OF ADEQUATE VENOUS RETURN • MAINTENANCE OF ADEQUATE SVR • PREVENTION OF PAIN, HYPOXAEMIA, HYPERCARBIA AND ACIDOSIS, WHICH MAY INCREASE PULMONARY VASCULAR RESISTANCE.
  32. 32. EPIDURAL ANALGESIA • ONE OF THE MAJOR ADVANTAGES OF EPIDURAL ANALGESIA IS THAT IT CAN BE ADMINISTERED IN INCREMENTAL DOSES AND THAT THE TOTAL DOSE COULD BE TITRATED TO THE DESIRED SENSORY LEVEL. • SLOWER ONSET OF ANAESTHESIA • THE SEGMENTAL BLOCKADE SPARES THE LOWER EXTREMITY “MUSCLE PUMP,” AIDING IN VENOUS RETURN, AND ALSO DECREASES THE INCIDENCE OF THROMBOEMBOLIC EVENTS. • INVASIVE HAEMODYNAMIC MONITORING, JUDICIOUS INTRAVENOUS ADMINISTRATION OF CRYSTALLOID AND ADMINISTRATION OF SMALL BOLUS DOSES OF PHENYLEPHRINE MAINTAIN MATERNAL HAEMODYNAMIC STABILITY. • NEURAXIAL BLOCK IN AN ANTICOAGULATED PATIENT HAS THE RISK OF EPIDURAL HAEMATOMA. Allows the maternal cardiovascular system to compensate for the occurrence of sympathetic blockade, resulting in a lower risk of hypotension and decreased uteroplacental perfusion.
  33. 33. COMBINED SPINAL-EPIDURAL PROCEDURE PER SE • CSE IS PERFORMED IN LATERAL DECUBITUS POSITION UNDER STRICT ASEPTIC PRECAUTIONS EPIDURAL SPACE IS IDENTIFIED WITH 18 G TUOHY NEEDLE USING LOR WITH SALINE. SPINAL NEEDLE IS INTRODUCED THROUGH THE TUOHY NEEDLE AND SUBARACHNOID BLOCK IS PERFORMED.20-30 ΜG OF FENTANYL ALONG WITH 2.5 -5MG OF 0.5% BUPIVACAINE IS GIVEN. THIS IS FOLLOWED BY INSERTION OF EPIDURAL CATHETER THROUGH WHICH 3 ML OF 2% XYLOCAINE WITH EPINEPHRINE IS GIVEN. • POST OPERATIVE ANALGESIA IS MAINTAINED AS SHOWN IN THE TABLE BELOW DRUG INITIAL INJECTION CONTINUOUS INFUSION • BUPIVACAINE 10-15 ML OF A 0.25%-0.125% SOLUTION 0.0625%-0.125% SOLUTION AT 8-15 ML/HR • ROPIVACAINE 10-15 ML OF A 0.1%-0.2% SOLUTION 0.5%-0.2% SOLUTION AT 8-15 ML/HR • FENTANYL 50-100 MICROGRAM IN A 10-ML VOLUME 1-4
  34. 34. MYTHS AND WORRIES ABOUT REGIONAL ANAESTHESIA 1. PRELOADING IS MANDATORY AND HAZARDOUS--CVP GUIDED FLUID MANAGEMENT NEGATES OVERLOADING AND MAINTAINS ADEQUATE CARDIAC OUTPUT 2. REGIONAL ANAESTHESIA IS ASSOCIATED WITH SUDDEN FALL IN BP. LOCAL ANAESTHETIC WITH OPIOID COMBINATION INTRATHECALLY FOLLOWED BY EPIDURAL TO TITRATE THE DESIRED LEVEL OF BLOCK DOES NOT PRODUCE RAPID FALL IN BP. 3. DELAY IN PERFORMING THE ACTUAL PROCEDURE: THIS DOESNT HAPPEN WITH EXPERT HANDS 4. THE COMPLICATIONS OF CSE-LIKE TOTAL SPINAL, LA TOXICITY, EPIDURAL HEMATOMA AND ABSCESS ARE NEGLIGIBLE WITH SENIOR ANESTHESIOLOGISTS.
  35. 35. REGIONAL ANAESTHESIA CONTROVERSIES ABOUT CSE: • RISK OF EPIDURAL CATHETER THROUGH THE DURAL HOLE • PERCEIVED INCREASE IN NEUROTRAUMA CONTRAINDICATIONS TO REGIONAL ANAESTHESIA • ACTIVE HEAVY BLEEDING • UNCORRECTED COAGULOPATHY (E.G. HELLP SYNDROME (HEMOLYSIS, ELEVATED LIVER ENZYMES, LOW PLATELETS) ASSOCIATED WITH PRE-ECLAMPSIA) • THROMBOCYTOPENIA • SYSTEMIC SEPSIS • LOCAL SEPSIS AT SITE OF INSERTION • PATIENT REFUSAL
  36. 36. GUIDELINES FOR GENERAL ANAESTHESIA • ANAESTHETIC GOALS: 1. MAINTAIN THE HEART RATE AROUND 80-100 B/MIN . 2. MAINTAIN LEFT ATRIAL PRESSURE HIGH ENOUGH TO TAKE ADVANTAGE OF THE INCREASED PRELOAD RESERVE. 3. AVOID PULMONARY ARTERY HYPERTENSION BY TREATING HYPERCARBIA, HYPOXEMIA, AND ACIDEMIA. 4. AGGRESSIVELY TREAT PULMONARY ARTERY HYPERTENSION WITH VASODILATOR THERAPY TO AVOID RV FAILURE. IF RV FAILURE DOES OCCUR, INOTROPIC SUPPORT OF THE RV AND PULMONARY VASODILATION MAY BE NECESSARY. THE PRESENCE OF PAH IS THE MAJOR FACTOR THAT INCREASE THE MORTALITY. GENERAL ANAESTHESIA HAS THE ADVANTAGES OF SPEED OF INDUCTION, CONTROL OF THE AIRWAY, AND SUPERIOR HEMODYNAMICS.
  37. 37. ANAESTHETIC GOALS 5. AVOID FACTORS WHICH DEPRESS THE MYOCARDIUM (INHALATION AGENTS AND DRUGS) 6. MAINTAIN AWARENESS OF POTENTIAL FOR LV RUPTURE. 7. AGGRESSIVE TREATMENT OF ARRHYTHMIAS IF THEY OCCUR 8. AVOID PROFOUND CHANGES IN SVR 9. ATTENUATE PRESSOR RESPONSE (INTUBATION, EXTUBATION, LIGHT PLANE OF ANESTHESIA) 10. ADEQUATE ANALGESIA AND ADEQUATE MUSCLE RELAXATION GUIDED BY NEURO MUSCULAR MONITORING 11. ASPIRATION PROPHYLAXIS 12. BLOOD LOSS ASSESSMENT AND PROMPT REPLACEMENT
  38. 38. GENERAL ANAESTHESIA • INDUCTION OF ANAESTHESIA 1. AVOID KETAMINE× – INCREASES HEART RATE, BLOOD PRESSURE 2. AVOID ATRACURIUM× – INCREASED HISTAMINE RELEASE CAUSES HYPOTENSION WHICH MANIFESTS AS TACHYCARDIA. • A BETA-ADRENERGIC RECEPTOR ANTAGONIST AND AN ADEQUATE DOSE OF OPIOID LIKE FENTANYL SHOULD BE ADMINISTERED BEFORE OR DURING THE INDUCTION OF GENERAL ANAESTHESIA. • ESMOLOL HAS A RAPID ONSET AND SHORT DURATION OF ACTION, IT IS A BETTER CHOICE IN CONTROLLING TACHYCARDIA. SINCE FOETAL BRADYCARDIA HAS BEEN REPORTED AFTER ESMOLOL, FOETAL HEART RATE SHOULD BE MONITORED.
  39. 39. GENERAL ANAESTHESIA • MAINTENANCE OF ANAESTHESIA 1. DRUGS SHOULD HAVE MINIMAL EFFECTS ON HEMODYNAMIC PATTERN 2. BALANCED ANAESTHESIA WITH N2O/ NARCOTIC/ VOLATILE ANAESTHETIC 3. N2O CAUSES INSIGNIFICANT PULMONARY VASOCONSTRICTION. IT IS SIGNIFICANT ONLY IF PULMONARY HYPERTENSION EXISTS. SO, ONE NEEDS TO TREAT PULMONARY HYPERTENSION PREOPERATIVELY. 4. CARDIAC STABLE MUSCLE RELAXANTS ARE TO BE USED. (PREFERABLY AVOID PANCURONIUM ×) 5. AVOID LIGHTER PLANES OF ANAESTHESIA (TO AVOID TACHYCARDIA) 6. FLUID MANAGEMENT: • AVOID HYPERVOLEMIA - -> WORSENS PULMONARY EDEMA • AVOID HYPOVOLEMIA - -> SACRIFICES ALREADY DECREASED LEFT VENTRICULAR FILLING, WHICH FURTHER DECREASES CARDIAC OUTPUT. HYPOVOLEMIA
  40. 40. GENERAL ANAESTHESIA • AFTER DELIVERY OF THE FOETUS, OXYTOCIN 10–20 U IN 1,000 ML OF CRYSTALLOID SHOULD BE ADMINISTERED AT A RATE OF 40– 80 MU/MIN. AN INFUSION OF OXYTOCIN CAN LOWER THE SVR AS WELL AS ELEVATE THE PULMONARY VASCULAR RESISTANCE, RESULTING IN A DROP IN CARDIAC OUTPUT. CARE MUST BE TAKEN DURING ITS ADMINISTRATION. • METHYLERGOMETRINE, OR 15-METHYLPROSTAGLANDIN F2, PRODUCES SEVERE HYPERTENSION, TACHYCARDIA AND INCREASED PULMONARY VASCULAR RESISTANCE. • POST-OPERATIVELY AVOID PAIN AS PAIN BEGETS HYPOVENTILATION WHICH LEADS TO RESPIRATORY ACIDOSIS, HYPOXEMIA WHICH MANIFESTS AS RAISED HEART RATE AND PULMONARY
  41. 41. ADVANTAGES OF GA 1. RAPIDLY ESTABLISHED 2. BETTER HEMODYNAMIC STABILITY 3. PREVENTION OF ASPIRATION AS THE AIRWAY IS ISOLATED 4. HIGH FIO2 -WHICH WILL REDUCE PVR 5. VENTILATION CONTROLLED TO AVOID HYPERCARBIA-WHICH WILL INCREASE PVR 6. FRC IS INCREASED BY CONTROLLED VENTILATION 7. VENTILATION OF ATELECTATIC AREAS – BETTER V/Q 8. SINUS RHYTHM CAN BE MAINTAINED. IN CASE OF SVT AND VENTRICULAR ARRHYTHMIAS PROMPTLY REVERTED BY CARDIOVERSION 9. PEAK AIRWAY PRESSURE CAN BE KEPT <20 CMS H2O 10. ELECTIVE POST OPERATIVE VENTILATION TO TIDE OVER THE CCF THAT MAY BE POSSIBLE AFTER PARTURITION 11. EFFECTIVE MANAGEMENT OF PULMONARY OEDEMA - IPPV WITH PEEP, LIBERAL USE OF HIGH DOSE MORPHINE
  42. 42. COMPLICATIONS OF GA 1. FAILED INTUBATION 2. ASPIRATION( MORE COMMON IN UNPREPARED CASE) 3. HYPERTENSIVE CRISIS 4. ARRHYTHMIA-HYPOXIA, HYPERCARBIA, INHALATIONAL AGENTS, DRUGS 5. USE OF POLY PHARMACY AND ANAPHYLAXIS 6. AWARENESS 7. UTERINE ATONY WITH INHALATION AGENTS 8. NEED FOR ADEQUATE POST OP. ANALGESIA 9. NEONATAL DEPRESSION 10. DELAYED RECOVERY 11. ANAESTHETIC DRUG INTERACTIONS 12. INCREASED INCIDENCE OF PONV 13. PROLONGED STAY ICU
  43. 43. OUTLINES OF MANAGEMENT 1. PRE-CONCEPTUAL COUNSELING- NYHA III AND IV ARE ADVISED CORRECTIVE CARDIAC BEFORE PREGNANCY. IT IS ADVISABLE FOR CERTAIN CARDIAC DISEASES WHERE PREGNANCY IS TO BE AVOIDED • THEY HAVE TO BE REGISTERED, INTERVIEWED REGARDING FUNCTIONAL DIFFICULTIES, REGULAR FOLLOW UPS STARTING FROM EARLY PREGNANCY. IT IS ADVISABLE TO MANAGE THEM IN HIGHER CENTERS WHERE MULTIDISCIPLINARY SUPPORT IS AVAILABLE(MULTIDISCIPLINARY APPROACH: MANAGEMENT BY A TEAM OF SPECIALISTS APART FROM OBSTETRICIANS THAT INCLUDES THE CARDIOLOGIST(FAILURE PREVENTION, ARRHYTHMIA MANAGEMENT), CT SURGEON(EMERGENT CARDIAC SURGERY), NEONATOLOGIST(PRETERM BABY) ANESTHESIOLOGIST(PAIN RELIEF-EPIDURAL, MECHANICAL VENTILATION IF NECESSARY) 2. CORRECT FACTORS WHICH WILL BURDEN THE CARDIAC LESION LIKE ANEMIA, OBESITY, HYPERTENSION, ARRHYTHMIA 3. PREVENTION OF INFECTION
  44. 44. OUTLINES OF MANAGEMENT 4. OPTIMIZATION OF HEART RATE WITH PHARMACOLOGICAL AGENTS 5. PREGNANCY IS A HYPERCOAGULABLE STATE, WHICH INCREASES THE RISK OF THROMBOEMBOLIC EVENTS, ESPECIALLY IN THE CARDIAC PATIENT WITH A PROSTHETIC HEART VALVE, VALVULAR HEART DISEASE, OR HEART FAILURE. ANTICOAGULANT THERAPY SHOULD BE CONSIDERED IN THESE HIGH-RISK PATIENTS TO PREVENT THROMBOEMBOLISM OR THROMBUS FORMATION. 6. IE PROPHYLAXIS -(AS PER THE ACOG GUIDELINES- SOME OF THE DRUGS RECOMMENDED BY ACC/AHA ARE NOT RECOMMENDED FOR PREGNANT PATIENTS) 7. MONITORS- OTHER THAN THE ASA STANDARDS RECOMMENDATION- ADVANCED MONITORS LIKE INVASIVE ARTERIAL PRESSURE, CVP -, PCWP AND TEE ARE RECOMMENDED. THEY SHOULD BE CONTINUED IN THE POST PARTUM PERIOD UPTO 72 HRS AT LEAST
  45. 45. OUTLINES OF MANAGEMENT 8. PLANNING THE MODE OF DELIVERY-VAGINAL DELIVERY IS BETTER TOLERATED(LESS BLOOD LOSS, LESS CATECHOLAMINE), PAIN RELIEF DURING LABOR - RECOMMENDED, SHORTENING THE SECOND STAGE- OUTLET FORCEPS, EPISIOTOMY. 9. LARGE BOLUSES OF OXYTOCICS SHOULD BE AVOIDED AS THEY CAUSE PROFOUND HYPOTENSION. ERGOMETRINE BETTER AVOIDED. PGF2 ALPHA AND MESOPROSTOL ARE USED CAUTIOUSLY. 10. IF PLANNED FOR CESAREAN SECTION CHOICE OF ANESTHETIC SHOULD BE DIRECTED TO KEEP THE HAEMODYNAMIC STABLE (AS NEAR NORMAL SYSTEMIC VASCULAR RESISTANCE, PRELOAD, AFTERLOAD AS POSSIBLE)ADEQUATE REPLACEMENT OF BLOOD LOSS. 11. ALL PATIENTS WITH CARDIAC DISEASE SHOULD BE KEPT IN HIGH DEPENDENCY UNIT AND MONITORED AFTER THE DELIVERY FOR A MINIMUM PERIOD OF 72HRS 12. PLAN AND ADVISE CARDIAC SURGERY IN THE SECOND TRIMESTER IF IS WARRANTED IN THE INTEREST OF THE MOTHER'S WELL BEING.
  46. 46. THANK YOU
  • ZixuanCheng2

    Sep. 19, 2021
  • VinduYadav

    Sep. 18, 2021
  • EuniceMokeira

    Jul. 25, 2021
  • AnushaAnnu1

    Jul. 24, 2021
  • HariniSabbathi1

    Jun. 23, 2021
  • KarthikMurugesan39

    Jun. 20, 2021
  • THANSEENAAH

    May. 28, 2021
  • VivekPatange1

    Mar. 29, 2021
  • ssuser082220

    Mar. 19, 2021
  • SwethaReddy261

    Mar. 15, 2021
  • AliHassan1387

    Mar. 5, 2021
  • NehaVyas34

    Feb. 25, 2021
  • AartiSingh119

    Feb. 20, 2021
  • swapna1345

    Feb. 20, 2021
  • DrHemasriLaxmi

    Feb. 17, 2021
  • rajkumarnitharwal1

    Jan. 23, 2021
  • allandeepak1

    Jan. 18, 2021
  • DivyaPrasad31

    Jan. 15, 2021
  • RamyaPrathap1

    Dec. 1, 2020
  • BKalpana1

    Nov. 18, 2020

Anaesthesiology

Aufrufe

Aufrufe insgesamt

14.541

Auf Slideshare

0

Aus Einbettungen

0

Anzahl der Einbettungen

41

Befehle

Downloads

462

Geteilt

0

Kommentare

0

Likes

102

×